Romiplostim Treatment for Thrombocytopenia in Patients With Wiskott-Aldrich Syndrome.
NCT04350164
·
clinicaltrials.gov ↗
COMPLETED
Status
67
Enrollment
OTHER
Sponsor class
Conditions
Wiskott-Aldrich Syndrome
Interventions
DRUG:
Romiplostim
Sponsor
Federal Research Institute of Pediatric Hematology, Oncology and Immunology